Effect of nitric oxide on lymphocytes from sporadic amyotrophic lateral sclerosis patients: Toxic or protective role?

Neurological Sciences

Volumn 27, Issue 5, 2006, Pages 312-316

  Cereda, Cristina ^a   Cova, E ^a   Di Poto, C ^a   Galli, A ^b   Mazzini, G ^c   Corato, M ^a   Ceroni, M ^a,b,c  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b Policlinico di Monza   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Bcl 2; Lymphocytes; Nitric oxide; Oxidative stress; SOD1

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; COPPER ZINC SUPEROXIDE DISMUTASE; NITRIC OXIDE; PROTEIN BCL 2;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; HUMANS; HYDRAZINES; LYMPHOCYTES; NITRIC OXIDE; NITRIC OXIDE DONORS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 37849186691     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0702-z     Document Type: Article

References (26)

1. Robberecht W (2000) Oxidative stress in amyotrophic lateral sclerosis. J Neurol 247[Suppl 1]:1-6
2. Simpson EP, Yen AA, Appel SH (2003) Oxidative Stress: A common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 15:730-736
3. Valentine JS, Hart PJ (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 100:3617-3622
4. Ferrante RJ, Browne SE, Shinobu LA et al (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 769:2064-2074
5. Chou SM, Wang HS, Komai K (1996) Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immunohistochemical study. J Chem Neuroanat 10:249-258
6. Sasaki S, Warita H, Abe K, Iwata M (2002) Neuronal nitric oxide synthase (nNOS) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene. Acta Neuropathol (Berl) 103:421-427
7. Aquilano K, Rotilio G, Ciriolo MR (2003) Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS. J Neurochem 85:1324-1335
8. Allen S, Heath PR, Kirby J et al (2003) Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J Biol Chem 278:6371-6383
9. Dawson VL, Dawson TM (1998) Nitric oxide in neurodegeneration. Prog Brain Res 118:215-229
10. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364:584
11. Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA (2004) Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: The role of vitagenes. In Vivo 18:245-267
12. Beal MF, Ferrante RJ, Browne SE et al (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42:644-654
13. Leist M, Nicotera P (1998) Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res 239:183-201
14. Ciriolo MR, De Martino A, Lafavia E et al (2000) Cu,Znsuperoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J Biol Chem 275:5065-5072
15. Curti D, Malaspina A, Facchetti G et al (1996) Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 47:1060-1064
16. Brooks BR, Miller RG, Swash M, Munsat TL (2000) World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revisited criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 1:293-299
17. Mazzini G, Ferrari C, Cereda C et al (2003) The dye pair HO33342 and propidium iodide allows the fast monitoring of cell membrane status by flow cytometry. Eur J Histochem 47:3 (Abstract)
18. Chung HT, Pae HO, Choi BM et al (2001) Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282:1075-1079
19. Cova E, Cereda C, Galli A et al (2006) Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci Lett 399:186-190
20. Sarker KP, Biswas KK, Rosales JL et al (2003) Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. J Neurochem 87:1345-1353
21. Yamasaki M, Mishima HK, Yamashita H et al (2005) Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res 1050:15-26
22. Calabrese V, Bates TE, Stella AM (2000) NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: The role of oxidant/antioxidant balance. Neurochem Res 25:1315-1341
23. Wink DA, Cook JA, Pacelli R et al (1995) Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett 82-83:221-226
24. Rosenberg PA, Li Y, Ali S et al (1999) Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. J Neurochem 73:476-484
25. Oteiza PI, Uchitel OD, Carrasquedo F et al (1997) Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 22:535-539
26. Ilzecka J (2003) Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients. Scand J Clin Lab Invest 63:297-302